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Plasmodium falciparum is the most deadly parasite, responsible for over I million deaths per year. Children living in sub-Saharan Africa bear the brunt of the disease. Although many children die before they reach health facilities, appropriate management in health clinics and District hospitals may significantly reduce the mortality'.
In severe falciparum malaria, simple, cheap interventions may make a significant impact on improving the outcome: antimalarials, antimicrobials, anticonvulsants, glucose and fluids (Table I) . Parenteral antimalarials (quinine dichloride or the artemisinin compounds) and blood transfusions are the only interventions that have been shown to reduce mortality. The use of these antimalarials are covered by guidelines issued by The World Health Organizationj-". Blood transfusions are discussed in these guidelines, but also in a paper by Pamba and Maitland on fluid management in this issue (p 67). Detection and prompt treatment of hypoglycaemia, seizures and hypovolaemia may also improve the outcome. Other complications such as hyperlacticacidaemia and bacteraemia are associated with death, but are less easy to detect in resource poor facilities. The role of antimicrobials will be discussed in a later issue of this journal.
In this issue of Tropical Doctor, we discuss the management of two common complications of severe malaria, i.e. hypovolaemia (Pamba and Maitland, p 67) and seizures (Ogutu and Newton, p 71). These complications are often not detected or are managed inappropriately in many health facilities -the appropriate interventions may reduce the mortality of severe falciparum malaria.
The Medicines Crossing Borders Projectimproving the quality of donations Normal saline 10 mL/kg boluses Broad spectrum cover depending on sensitivities of local bacteria. 5hould include cover for Gram-negative organisms A recent example in the British Medical Journal highlighted the moral dilemmas that can distort the arguments for sound drug donations to the developing world. It suggested that from a doctor's point of view six vials of a third generation cephalosporin antibiotic could save the life of a child with meningitis even though the drug's expiry date may have passed and its use therefore breached drug donations guidelines'.
Emergencies may necessitate breaking the rules, but sensible drug donation guidelines need to be adhered to if the rich world's good intentions are not seriously to undermine progress in the developing world. That is why a quarter of a century after the World Health Organization's (WHO) first attempts at regulation in the International Medicines Crossing Borders project, supported by the European Commission, is busy promoting a step-by-step guide on 'good drug donation practices' and is now pressing for a monitoring system.
The idea is to try to inform an increasingly wide spectrum of donors from medical students and sympathetic tourists to non-governmental organizations (NGOs), pharmacists, church groups and industry. It will be available in English, French, Spanish, German and Dutch, and will be in the form of a checklist to ensure the quality of donations once ready for shipment or evaluate a donation once made. Inappropriate drugs may not only be useless, they can drain already scarce resources. Nicaragua was left with the problem of disposing inappropriate donations delivered during the disaster relief for Hurricane Mitch. They could not be shipped back to the European Union (EU) on the grounds that they were toxic. In 1994 private voluntary organizations donated large quantities of sophisticated antibiotics to Rwandan refugee camps. Refugee workers, however, had no experience of using the drug so most had to be withdrawn -the rest posed disposal problems.
Anecdotal evidence aside, the true scale of inappropriate donations was suggested by France's Pharmaciens Sans Frontieres which found that in 1991 only 20% of the 4 million kg of drugs collected from 4000 French pharmacies for international aid programmes could be used, the rest had to be burnt.
Well-intentioned dumping of large amounts of free drugs may actually damage developing countries nascent efforts at local manufacturing. The local production of affordable generic drugs cannot compete in a market flooded with foreign donations. The WHO highlights the difficulties caused in Guinea-Bissau in 1983 when 8 tons of drugs donated from pharmacies arrived in 22123 packages containing 1714 different drugs in quantities of between 1-100 tablets. These were difficult to manage and, say the WHO, 'greatly interfered with government efforts to rationalize drug supply and drug use'.
While some countries in sub-Saharan and central Africa may be entirely dependent on donations or imports, many developing countries have at least some production capacity. These range from countries such as India, Brazil and Mexico that can handle complex processes, to a block of nearly 100 countries such as the Dominican Republic or Pakistan which are able to produce finished products for their domestic market from imported compounds. Still mission houses in India and Brazil make strong appeals for drugs despite strong local generic production.
Eritrea is a telling example of how the opposite is also true. Frustration during their war of independence with waiting for donated medicines, which when they arrived were often useless, led the Eritreans to develop their own manufacturing plant for the most commonly used medicines. Today this now forms the basis of its national manufacturing programme. Inappropriate donations can also undermine local efforts to promote standard drug lists based on effective and safe treatment of their common diseases. Rational prescribing, procurement of affordable generic drugs and training based on familiarity with generic names can all suffer. For example, in Frenchspeaking African countries efforts are being made to organize public health centres using essential generic 66 drugs but the constant flow of donations from collected drugs upsets these sustainable national systems. Significantly, the youngest nation in the world, East Timor, already has a national standard drugs list and a procurement policy that prevents inappropriate donations.
The WHO Essential Drugs List, updated every 2 years, strongly influences national lists of essential drugs and is therefore seen as the starting point for donations. It contains more than 300 ingredients though 95% of drugs listed are generic. Since 1996 the WHO have drawn up guidelines specifically for drug donations based on a series of rules including: how the drug has been selected, quality assurance, presentation and information.'. Drugs should be requested by the recipient and appear on their national essential drugs list. Neither should there be double standards with donors. Drugs must not be free samples nor have been returned to pharmacists by patients. They should also have a shelf life of at least 1 year after reaching the recipient country. In addition, the language on labels should be understandable and should include the generic name, the expiry date and the recommended dosage. By last year six donor countries and 13 recipient countries had also developed their own drug donation guidelines.
Today, building on the WHO guidelines, comes further advice, a step-by-step guide called Good Drug Donation Practices produced by the Medicines Crossing Borders project. The project is supported by the European Commission and run by an international health consortium comprising Dutch health and development NGO Wemos, together with DIFAM from Germany, Prosalus from Spain and ReMed from France. It was launched following an experts meeting in 1999, which decided that efforts across Europe needed to be pooled to address problems with drug donations. It is aiming both to address an increasingly wide spectrum of donors and to lobby for changes in governments' policies. It is also aiming at both the general public and specific target groups. Leaflets, flyers, posters and a video, Making Drug Donations Better With Care are available, and a website [www.drugdonations.nl] has been launched.
Campaigns directed at government agencies have contributed to the Netherlands making illegal the practice of donating returned drugs. In Germany health minister Ulla Schmidt has strongly recommended implementing a declaration on good donation practice, while Spanish NGO Farmaceuticos Mundi has started sending generic medicines to NGOs in developing countries rather than returned drugs.
The consortium is now pressing for permanent solutions. WHO guidelines need to be given some teeth by developing a drug management system that can ensure adherence to the guidelines. Meanwhile drug donations not meeting the guidelines should be banned by the EU.
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